• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类鸟氨酸转氨甲酰酶基因座上额外限制性片段长度多态性的鉴定与应用。

Identification and application of additional restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.

作者信息

Fox J E, Hack A M, Fenton W A, Rosenberg L E

出版信息

Am J Hum Genet. 1986 Jun;38(6):841-7.

PMID:3014867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1684839/
Abstract

Two additional restriction fragment length polymorphisms (RFLPs) have been identified at the human ornithine transcarbamylase (OTC) locus. Approximately 11% of women are heterozygous for an RFLP characterized by polymorphic bands at 3.7 and 3.6 kilobasepairs (kbp) observed after DNA digestion with TaqI. Twenty-nine percent of women are heterozygous for an RFLP characterized by polymorphic bands at 18.0 and 5.2 kbp observed after digestion with BamHI. Thus, in combination with the previously reported RFLPs identified using MspI, the X chromosomes in approximately 80% of women at risk for having a son with OTC deficiency are distinguishable by RFLPs at the OTC locus. Furthermore, we show that these RFLPs will be useful in families for prenatal diagnosis of OTC deficiency, carrier detection, and carrier exclusion.

摘要

在人类鸟氨酸转氨甲酰酶(OTC)基因座上又鉴定出了两种限制性片段长度多态性(RFLP)。大约11%的女性为一种RFLP的杂合子,其特征是在用TaqI消化DNA后观察到3.7和3.6千碱基对(kbp)处有多态性条带。29%的女性为一种RFLP的杂合子,其特征是在用BamHI消化后观察到18.0和5.2 kbp处有多态性条带。因此,与先前报道的使用MspI鉴定出的RFLP相结合,在有生出患OTC缺乏症儿子风险的约80%女性中,其X染色体可通过OTC基因座处的RFLP加以区分。此外,我们表明这些RFLP在家庭中对于OTC缺乏症的产前诊断、携带者检测和携带者排除将是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/8d9533484ff1/ajhg00155-0055-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/9e49cbf101a1/ajhg00155-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/194faa5bebf4/ajhg00155-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/8d9533484ff1/ajhg00155-0055-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/9e49cbf101a1/ajhg00155-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/194faa5bebf4/ajhg00155-0054-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec41/1684839/8d9533484ff1/ajhg00155-0055-a.jpg

相似文献

1
Identification and application of additional restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.人类鸟氨酸转氨甲酰酶基因座上额外限制性片段长度多态性的鉴定与应用。
Am J Hum Genet. 1986 Jun;38(6):841-7.
2
Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.
Nature. 1985;313(6005):815-7. doi: 10.1038/313815a0.
3
DNA analysis for ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的DNA分析
J Inherit Metab Dis. 1986;9 Suppl 1:49-57. doi: 10.1007/BF01800858.
4
Detection and exclusion of carriers of ornithine transcarbamylase deficiency by RFLP analysis.通过限制性片段长度多态性分析检测和排除鸟氨酸转氨甲酰酶缺乏症携带者
Clin Genet. 1986 May;29(5):449-52. doi: 10.1111/j.1399-0004.1986.tb00520.x.
5
Improved molecular diagnostics for ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的分子诊断技术改进
Am J Hum Genet. 1991 Feb;48(2):212-22.
6
New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的新突变与产前诊断
Am J Hum Genet. 1986 Feb;38(2):149-58.
7
Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因MspI位点由C突变为T导致的致命性高氨血症。
Hum Genet. 1991 Dec;88(2):153-6. doi: 10.1007/BF00206063.
8
First specific preimplantation genetic diagnosis for ornithine transcarbamylase deficiency.首例针对鸟氨酸转氨甲酰酶缺乏症的特定植入前基因诊断。
Prenat Diagn. 2000 Dec;20(13):1048-54. doi: 10.1002/1097-0223(200012)20:13<1048::aid-pd975>3.0.co;2-8.
9
Structure of the ornithine transcarbamylase (OTC) gene and DNA diagnosis of OTC deficiency.鸟氨酸转氨甲酰酶(OTC)基因结构与OTC缺乏症的DNA诊断。
Clin Chim Acta. 1989 Dec 15;185(3):283-9. doi: 10.1016/0009-8981(89)90218-0.
10
Restriction fragment length polymorphisms at the ornithine transcarbamylase locus in normal Chinese.
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1990 Jul-Aug;31(4):221-5.

引用本文的文献

1
Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].5例日本男性新生儿或迟发性鸟氨酸转氨甲酰酶缺乏症患者中的4种新基因突变:聚合酶链反应-单链构象多态性在外显子及相邻内含子中的应用[已修正]
Hum Genet. 1993 Aug;92(1):49-56. doi: 10.1007/BF00216144.
2
Family studies in ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的家系研究。
Arch Dis Child. 1988 Mar;63(3):297-302. doi: 10.1136/adc.63.3.297.
3
Diagnosis of genetic disease using recombinant DNA. Supplement.

本文引用的文献

1
Therapy of urea cycle enzymopathies: three case studies.尿素循环酶病的治疗:三个病例研究。
Johns Hopkins Med J. 1981 Jan;148(1):34-40.
2
Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症无症状携带者的脑功能障碍
N Engl J Med. 1980 Feb 28;302(9):482-5. doi: 10.1056/NEJM198002283020902.
3
Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.尿素合成先天性缺陷的治疗:激活废氮合成与排泄的替代途径。
使用重组DNA进行遗传病诊断。增刊。
Hum Genet. 1987 Sep;77(1):66-75. doi: 10.1007/BF00284717.
4
Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency.三名无关的鸟氨酸转氨甲酰酶缺乏症患者同一精氨酸密码子点突变的特征分析
J Clin Invest. 1988 Oct;82(4):1353-8. doi: 10.1172/JCI113738.
5
Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency.一种部分显性X连锁疾病的携带者检测:鸟氨酸转氨甲酰酶缺乏症
Hum Genet. 1990 Jan;84(2):167-71. doi: 10.1007/BF00208934.
6
Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.导致人类鸟氨酸转氨甲酰酶缺乏症的RNA剪接错误的鉴定。
Am J Hum Genet. 1991 Jun;48(6):1105-14.
7
Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.鸟氨酸转氨甲酰酶基因MspI位点由C突变为T导致的致命性高氨血症。
Hum Genet. 1991 Dec;88(2):153-6. doi: 10.1007/BF00206063.
8
Improved molecular diagnostics for ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症的分子诊断技术改进
Am J Hum Genet. 1991 Feb;48(2):212-22.
9
Site specific screening for point mutations in ornithine transcarbamylase deficiency.鸟氨酸转氨甲酰酶缺乏症点突变的位点特异性筛查。
J Med Genet. 1992 Jul;29(7):471-5.
N Engl J Med. 1982 Jun 10;306(23):1387-92. doi: 10.1056/NEJM198206103062303.
4
Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.尿素合成先天性代谢缺陷患儿的神经学转归。尿素循环酶病的转归。
N Engl J Med. 1984 Jun 7;310(23):1500-5. doi: 10.1056/NEJM198406073102304.
5
Prenatal diagnosis of ornithine transcarbamylase deficiency utilizing fetal liver biopsy.利用胎儿肝活检进行鸟氨酸转氨甲酰酶缺乏症的产前诊断。
Am J Hum Genet. 1984 Mar;36(2):320-8.
6
Molecular cloning of the cDNA coding for rat ornithine transcarbamoylase.编码大鼠鸟氨酸转氨甲酰酶的cDNA的分子克隆。
Proc Natl Acad Sci U S A. 1983 Jul;80(14):4258-62. doi: 10.1073/pnas.80.14.4258.
7
Regional localization on the human X of DNA segments cloned from flow sorted chromosomes.从流式分选染色体克隆的DNA片段在人类X染色体上的区域定位。
Nucleic Acids Res. 1982 Mar 11;10(5):1557-78. doi: 10.1093/nar/10.5.1557.
8
Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.尿素合成先天性代谢缺陷患儿发作性高氨血症的治疗
N Engl J Med. 1984 Jun 21;310(25):1630-4. doi: 10.1056/NEJM198406213102503.
9
Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase.人线粒体鸟氨酸转氨甲酰酶核编码前体的互补DNA的结构与表达
Science. 1984 Jun 8;224(4653):1068-74. doi: 10.1126/science.6372096.
10
Direct identification of sickle cell anemia by blot hybridization.通过印迹杂交直接鉴定镰状细胞贫血。
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5081-5. doi: 10.1073/pnas.78.8.5081.